EUVIMEDEUVIMED entdecken
Open Access

Inhibition of nitric oxide synthase transforms carotid occlusion-mediated benign oligemia into de novo large cerebral infarction

Ha Kim, Jinyong Chung, Jeong Wook Kang, Dawid Schellingerhout, Soo Ji Lee, Hee Jeong Jang, Inyeong Park, Taesu Kim, Dong-Seok Gwak, Ji Sung Lee, Sung-Ha Hong, Kang-Hoon Je und 6 weitere

Theranostics · 2025

DOI: 10.7150/thno.104132 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2025. Verfasst von Ha Kim und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of neurology, Dongguk University Ilsan Hospital, Goyang 10326, Republic of Korea. Hauptthemen laut MEDLINE: Cerebral Infarction, Mice, Inbred C57BL, NG-Nitroarginine Methyl Ester, Nitric Oxide Synthase. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rationale

It remains unclear why unilateral proximal carotid artery occlusion (UCAO) causes benign oligemia in mice, yet leads to various outcomes (asymptomatic-to-death) in humans. We hypothesized that inhibition of nitric oxide synthase (NOS) both transforms UCAO-mediated oligemia into full infarction and expands pre-existing infarction.

Methods

Using 900 mice, we i) investigated stroke-related effects of UCAO with/without intraperitoneal administration of the NOS inhibitor (NOSi) Nω-nitro-L-arginine methyl ester (L-NAME, 400 mg/kg); ii) examined the rescue effect of the NO-donor, molsidomine (200 mg/kg at 30 minutes); and iii) tested the impact of antiplatelet medications. To corroborate preclinical findings, we conducted clinical studies.

Results

UCAO alone induced infarction rarely (~2%) or occasionally (~14%) in C57BL/6 and BALB/c mice, respectively. However, L-NAME+UCAO induced large-arterial infarction in ~75% of C57BL/6 and BALB/c mice. Six-hour laser-speckle imaging detected spreading ischemia in ~40% of C57BL/6 and BALB/c mice with infarction (vs. none without) by 24-hours. In agreement with vasoconstriction/microthrombus formation shown by intravital-microscopy, molsidomine and the endothelial-NOS-activating antiplatelet cilostazol attenuated/prevented progression to infarction. Moreover, UCAO without L-NAME caused infarction in ~22% C57BL/6 and ~31% ApoE knock-out mice with hyperglycemia/hyperlipidemia, which associated with ~60% greater levels of symmetric dimethylarginine (SDMA, an endogenous NOSi). Further, increased levels of glucose and cholesterol associated with significantly larger infarct volumes in 438 UCAO-stroke patients. Lastly, Mendelian randomization identified a causative role of NOS inhibition (elevated SDMA concentration) in ischemic stroke risk (OR = 1.24; 95% CI, 1.11-1.38; P = 7.69×10-5).

Conclusion

NOS activity determines the fate of hypoperfused brain following acute UCAO, where SDMA could be a potential risk predictor.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cerebral InfarctionMice, Inbred C57BLNG-Nitroarginine Methyl EsterNitric Oxide SynthaseDisease Models, AnimalMice, Inbred BALB CAnimalsMiceMaleHumansEnzyme InhibitorsFemaleMiddle AgedAgedStroke

Stichwörter der Autor:innen

carotid artery occlusioncerebral infarctionnitric oxide synthaseoligemiastroke

Substanzen

NG-Nitroarginine Methyl EsterNitric Oxide SynthaseEnzyme Inhibitors

Autor:innen und Institutionen

  • Department of neurology, Dongguk University Ilsan Hospital, Goyang 10326, Republic of Korea.
  • National Priority Research Center for Stroke, Goyang 10326, Republic of Korea.
  • Medical Science Research Center, Dongguk University, Goyang 10326, Republic of Korea.
  • Departments of Neuroradiology and Imaging Physics, University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA.
  • Genome & Health Big Data Laboratory, Department of Public Health, Graduate School of Public Health, Seoul National University, Seoul 08826, Republic of Korea.
  • Health & Environment Institute, Seoul National University, Seoul 08826, Republic of Korea.

Förderung

  • NINDS NIH HHS

Zitieren

APA

Kim, H., Chung, J., Kang, J. W., Schellingerhout, D., Lee, S. J., Jang, H. J., Park, I., Kim, T., Gwak, D. S., Lee, J. S., Hong, S. H., Je, K. H., Bae, H. J., Sung, J., Lo, E. H., Faber, J., Ayata, C., & Kim, D. E. (2025). Inhibition of nitric oxide synthase transforms carotid occlusion-mediated benign oligemia into de novo large cerebral infarction. Theranostics. https://doi.org/10.7150/thno.104132

Vancouver

Kim H, Chung J, Kang JW, Schellingerhout D, Lee SJ, Jang HJ, et al. Inhibition of nitric oxide synthase transforms carotid occlusion-mediated benign oligemia into de novo large cerebral infarction. Theranostics. 2025. doi:10.7150/thno.104132

BibTeX
@article{Kim2025,
  author = {Kim, Ha and Chung, Jinyong and Kang, Jeong Wook and Schellingerhout, Dawid and Lee, Soo Ji and Jang, Hee Jeong and Park, Inyeong and Kim, Taesu and Gwak, Dong-Seok and Lee, Ji Sung and Hong, Sung-Ha and Je, Kang-Hoon and Bae, Hee-Joon and Sung, Joohon and Lo, Eng H and Faber, James and Ayata, Cenk and Kim, Dong-Eog},
  title = {Inhibition of nitric oxide synthase transforms carotid occlusion-mediated benign oligemia into de novo large cerebral infarction},
  journal = {Theranostics},
  year = {2025},
  doi = {10.7150/thno.104132}
}
Kostenlos starten →